Kestra Medical Technologies, Ltd.
KMTS
$26.07
-$0.33-1.25%
NASDAQ
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 07/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -29.88% | -133.59% | 0.51% | 20.81% | |
| Total Depreciation and Amortization | -14.61% | -47.57% | -43.86% | 1.17% | |
| Total Amortization of Deferred Charges | 134.50% | 84.50% | -13.71% | 87.79% | |
| Total Other Non-Cash Items | 142.69% | 1,972.01% | 19.95% | -30.71% | |
| Change in Net Operating Assets | -315.06% | -256.92% | -91.67% | -1,492.27% | |
| Cash from Operations | -50.15% | -58.54% | -16.38% | 15.65% | |
| Capital Expenditure | -17.17% | -91.48% | 18.22% | -321.94% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 60.87% | 573.81% | -- | -80.83% | |
| Cash from Investing | -17.03% | -86.61% | 18.17% | -353.08% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -100.00% | -100.00% | 313.60% | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -114.59% | -1,210.61% | 80.27% | 1,224.99% | |
| Cash from Financing | -101.61% | 1,654.68% | -101.00% | 333.84% | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -139.67% | 2,766.90% | -154.58% | 1,939.13% | |